Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of mouse embryoid body differentation in a time series
Expression profiling of a 16 day mouse embryoid body (EB) differentiation time course.
ORGANISM(S): Mus musculus 
2008-06-01 | E-TABM-433 | biostudies-arrayexpress
UnknownInsightful practice: a reliable measure for medical revalidation.
Not available
S-EPMC3404544 | biostudies-literature
TranscriptomicsTranscription profiling of human skeletal muscle reflects responses to inadequate protein intake in younger and older males
Inadequate protein intake initiates an accommodative response with adverse changes in skeletal muscle function and structure. mRNA level changes due to short-term inadequate dietary protein might be an early indicator of accommodation. The aims of this study were to assess the effects of dietary p...
ORGANISM(S): Homo sapiens 
2008-10-26 | E-GEOD-9419 | biostudies-arrayexpress
TranscriptomicsmTOR inhibitors synergistically induce regression, reversal of gene expression and autophagy in hepatocellular carcinoma
The mTOR-allosteric inhibitor, RAD001, in combination with a PI3K/mTOR ATP-site competitive inhibitor, BEZ235, causes gene reprogramming, autophagy and tumor regression, in a mouse model approximating human HCC with poor prognosis, leading to an investigator Phase 1B-2 clinical trial. Comparative st...
ORGANISM(S): Mus musculus 
2012-07-11 | E-GEOD-37129 | biostudies-arrayexpress
UnknownRisk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Not available
S-EPMC4431340 | biostudies-literature
UnknownThe influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.
Not available
S-EPMC3371225 | biostudies-literature
UnknownPsoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response.
Not available
S-EPMC10898332 | biostudies-literature
UnknownMutation and association analysis of GEN1 in breast cancer susceptibility.
Not available
S-EPMC3632835 | biostudies-literature
UnknownGermline mutations in RAD51D confer susceptibility to ovarian cancer.
Not available
S-EPMC4845885 | biostudies-literature
UnknownEffects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
Not available
S-EPMC6617509 | biostudies-literature
Sort   by:  
 Page size